Enzyme-Based Organic Synthesis. Cheanyeh ChengЧитать онлайн книгу.
acceptor in general involves two steps: (i) the release of an amino group from the amino donor (deamination) and (ii) the addition of the amino group to the amino acceptor (amination). For this kind of transamination reaction, a vitamin B6‐based pyridoxal 5′‐phosphate (PLP) is required as a cofactor for transaminase to act as an intermediate amine acceptor and electron sink. Since the cofactor releases the amino group and restores its initial state at the end of the transamination, there is no need to carry out additional cofactor regeneration for the enzyme [1, 2]. However, the use of transaminases in organic synthesis still suffers from the problem of unfavorable reversible reaction equilibrium. This problem is especially serious when an amino acid is used as amino donor in the asymmetric synthesis of amines.
To shift the reaction equilibrium to the product side of the transamination reactions catalyzed by transaminase, a conventional strategy that has been commonly used is to provide an excessive amount of the amino donor. Scheme 3.1 illustrates an example in which an excess amount of isopropyl amine was applied to push the transamination of acetophenone to 1‐phenylethylamine toward complete conversion and an enantiomeric excess of >99% [3]. In addition to the method of using excessive cosubstrate for shifting the equilibrium toward the product side, other methods such as removal of product or coproduct by vaporization, extraction, autodegrading smart coproducts, and biochemical cascade reactions were also utilized in many cases [1].
Scheme 3.1 The transamination between acetophenone and excessive isopropyl amine with transaminase.
Source: Truppo et al. [3].
Another smart synthesis strategy is the combination of transaminase with other biocatalysts to form enzymatic cascade reactions that have been used to efficiently produce unnatural amino acids, optically pure amines, imines, secondary amines, and amides, or for the amination on the –OH or –CH3 functional group, or for the amines with two stereocenters. The enzymatic cascade reactions in organic synthesis give the advantages of shortening reaction routes, avoiding unstable or toxic intermediate, increasing the atom efficiency, and reducing the amount of wastes [1]. Most importantly, the enzymatic cascade reactions involving transaminases show prominent potential for many industrial applications [2].
There have been many examples to demonstrate the use of ω‐transaminase (ω‐TA) for producing unnatural amino acids such as L‐tert‐leucine and L‐phosphinothricine [4]. One of the many examples employing coupled enzyme reactions for synthesizing the unnatural amino acids was the production of the unnatural L‐homoalanine from L‐threonine by combining a threonine deaminase (TD) with the ω‐TA and using an one‐pot reaction process (Scheme 3.2) that resulted a 91% conversion [5]. The source of TD was from a cloned and overexpressed Escherichia coli and the (S)‐specific ω‐TA was from Paracoccus denitrificans. The formation of N‐benzylacetamide from benzaldehyde through an efficient one‐pot biocatalytic amine transaminase/acyl transferase cascade using methyl acetate as acyl donor is shown in Scheme 3.3 [6].
The conversion of the amide product in this enzymatic cascade reaction was up to 97% with an acyl transferase (AcT) from Mycobacterium smegmatis and an amine transaminase from Silicibacter pomeroyi.
Scheme 3.2 Enzyme cascade reactions for the conversion of L‐threonine to L‐homoalanine using a one‐pot reaction process.
Source: Modified from Park et al. [5].
Scheme 3.3 The formation of N‐benzylacetamide from benzaldehyde through an efficient one‐pot biocatalytic amine transaminase/acyl transferase cascade.
Source: Based on Land et al. [6].
Instead of compounds with one stereocenter, chiral amino alcohols with two stereocenters can be synthesized by the enzymatic cascade reactions without using protection step for the first stereocenter before the production of the second stereocenter. Scheme 3.4 shows an example of the enzymatic cascade route toward all four diastereomers of 4‐amino‐1‐phenylpentane‐2‐ol started from a racemic 1,3‐hydroxy ketone [7].
Scheme 3.4 The enzymatic cascade route toward all four diastereomers of 4‐amino‐1‐phenylpentane‐2‐ol from a compound with two stereocenters.
Source: Modified from Kohls et al. [7].
The first synthesis step of these four 1,3‐amino alcohol diastereomers was through the kinetic resolution for a racemic 1,3‐hydroxy ketone by applying using an (S)‐selective keto reductase (KRED) to regioselectively provide the optically pure (R)‐hydroxyl ketone (86% e.e.) and the corresponding diketone. Further transamination of the (R)‐hydroxyl ketone using either an (R)‐ or an (S)‐selective TA yields the (2R,4R)‐ and (2R,4S)‐1,3‐amino alcohol diastereomers.
The diketone was then used to prepare the remaining two diastereomers, (2S,4S)‐ and (2S,4R)‐1,3‐ amino alcohol, by first converting the diketone to (S)‐1,3‐hydroxy ketone and subsequently using either an (R)‐ or an (S)‐selective TA to stereoselective amination of the (S)‐1,3‐hydroxy ketone to (2S,4R)‐1,3‐amino alcohol and (2S,4S)‐1,3‐amino alcohol, respectively.
The industrial applications of enzymatic cascade reactions can be demonstrated by the in vitro biosynthesis of the nylon‐6 monomer 6‐aminohexanoic acid (hydrolyzed ε‐caprolactam) from cyclohexanol as illustrated by Scheme 3.5 [8]. In addition to transaminase, this enzymatic cascade route additionally involves a Baeyer–Villiger monooxygenase (BVMO) and an esterase that all these biocatalysts can function independently in a one‐pot synthesis under mild conditions. Two cofactor self‐sufficient cascade modules are involved in this route. One is for the production of ε‐caprolactone from cyclohexanol, the other is the subsequent production of 6‐aminohexanoic acid. This biosynthesis route thus shows advantages over chemical approaches that require sophisticated transition‐metal catalysts and high temperature and pressure.
Generally, the asymmetric amination of prochiral ketones with an amine donor employing ω‐transaminases (ω‐TAs) is performed in aqueous medium. Since most ketones are lipophilic with only moderately soluble in aqueous solution, the transformations involving ω‐TAs require the addition of an organic cosolvent, and enzyme engineering might be necessary to let it stand the harsher reaction conditions. In addition, the amination of prochiral ketones with